Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism

Miehsler, W; Reinisch, W; Valic, E; Osterode, W; Tillinger, W; Feichtenschloger, T; Grisar, J; Machold, K; Scholz, S; Vogelsang, H
April 2004
Gut;Apr2004, Vol. 53 Issue 4, p542
Academic Journal
Background: Patients with inflammatory bowel disease (IBD) are thought to be at increased risk of venous thromboembolism (TE). However, the extent of this risk is not known. Furthermore, it is not known if this risk is specific for IBD or if it is shared by other chronic inflammatory diseases or other chronic bowel diseases. Aims: To compare the risk of TE in patients with IBD, rheumatoid arthritis, and coeliac disease with matched control subjects. Patients and methods: Study subjects answered a questionnaire assessing the history of TE, any cases of which had to be confirmed radiologically. A total of 618 patients with IBD, 243 with rheumatoid arthritis, 207 with coeliac disease, and 707 control subjects were consecutively included. All three patient groups were compared with control subjects matched to the respective group by age and sex. Results: Thirty eight IBD patients (6.2%) had suffered TE. This was significantly higher compared with the matched control population with only 10 cases reported (1.6%) (p<0.001 odds ratio (OR) 3.6 (95% confidence interval (CI) 1 .7-7.8)). Five patients with rheumatoid arthritis (2.1%) had suffered TE compared with six subjects (2.5%) in the control population matched to patients with rheumatoid arthritis (NS; OR 0.7 (95% CI 0.2-2.9)). TE had occurred in two patients with coeliac disease (1%) compared with four subjects (1.9%) in the control population matched to the coeliac disease group (NS; OR 0.4(95% CI 0.1-2.5)). In 60% of TE cases in the IBD group, at least one IBD specific factor (active disease, stenosis, fistula, abscess) was present at the time TE occurred. Conclusions: IBD is a risk factor for TE. It seems that TE is a specific feature of IBD as neither rheumatoid arthritis, another chronic inflammatory disease, nor coeliac disease, another chronic bowel disease, had an increased risk of TE.


Related Articles

  • RESEARCH BRIEFS: Bowel disease affects thrombosis risk.  // GP: General Practitioner;3/22/2004, p10 

    Patients with inflammatory bowel disease have almost four times the risk of developing a venous thromboembolism compared with controls, according to Austrian researchers. The study found neither rheumatoid arthritis nor coeliac disease was associated with an increased risk.

  • Curcumin for inflammatory bowel disease. Gaby, Alan R. // Townsend Letter;Feb/Mar2006, Issue 271/272, p30 

    The article offers information about the curcumin, a component of the common spice called turmeric. Animal studies demonstrated an anti-inflammatory effect of curcumin, an un uncontrolled trial in humans that might be beneficial in the treatment of rheumatoid arthritis. Curcumin may also be an...

  • Interleukin 15: its role in intestinal inflammation. van Heel, D. A. // Gut;Apr2006, Vol. 55 Issue 4, p444 

    Interleukin 15 may have a central role in diverse intestinal inflammatory diseases, such as coeliac disease and inflammatory bowel disease, and hence manipulation of the IL-15 pathway may have therapeutic possibilities in these conditions.

  • Venous thrombosis in inflammatory bowel disease. Mian, Hira S.; Lawlor, Raymond // CMAJ: Canadian Medical Association Journal;1/6/2015, Vol. 187 Issue 1, p55 

    The article

  • Small bowel infarction in a patient with coeliac disease. McNeill, A.; Duthie, F.; Galloway, D. J. // Journal of Clinical Pathology;Feb2006, Vol. 59 Issue 2, p216 

    A 40 year old man was admitted with a four week history of intractable, diarrhoea and abdominal pain. A clinical diagnosis of inflammatory bowel disease was supported by biopsies of colonic mucosa. There was no response to Mesalazine and over 12 days the patient became critically ill with...

  • The significance of the gut barrier in disease. Meddings, Jon // Gut;Apr2008, Vol. 57 Issue 4, p438 

    The author comments on the study which identifies shared mechanisms in the genesis of coeliac disease or inflammatory bowel disease (IBD). He believes that these observations are necessary with regards to the recent belief that IBD is a represented dysregulation of the adaptive immune system and...

  • Latent coeliac disease or coeliac disease beyond villous atrophy? Kaukinen, Katri; Collin, Pekka; Mäki, Markku // Gut;Oct2007, Vol. 56 Issue 10, p1339 

    The article presents the author perspective on the characteristics and symptoms of celiac disease. It has been defined as an autoimmune-mediated enteropathy triggered in genetically susceptible persons by the ingestion of a single dietary factor, like wheat, rye and barley-derived gluten. The...

  • IBS vs. IBD and other tummy aches. Moore, Elaine // MLO: Medical Laboratory Observer;May2007, Vol. 39 Issue 5, p12 

    The article examines the difference between irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD), which is often confused with celiac disease and other enteropathies. IBS is a common functional gastrointestinal disorder that causes increased contractions or spasms of the colon or...

  • Lymphocytic Duodenosis and the Spectrum of Celiac Disease. Voort, Jennifer L. Vande; Murray, Joseph A.; Lahr, Brian D.; Van Dyke, Carol T.; Kroning, Cynthia M.; Moore, S. Breanndan; Tsung-Teh Wu // American Journal of Gastroenterology;Jan2009, Vol. 104 Issue 1, p142 

    OBJECTIVES: Celiac disease (CD) is a chronic inflammatory disease of the small bowel that is characterized by increased intraepithelial lymphocytes (IELs) and villous atrophy of the mucosa. It is unclear how often intraepithelial lymphocytosis in the absence of atrophy is a manifestation of...


Read the Article


Sign out of this library

Other Topics